Yong Li
Guangzhou University of Chinese Medicine(CN)Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine(CN)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment, Neuroendocrine Tumor Research Advances, Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer
Most-Cited Works
- → Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors(2017)55 cited
- → Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma(2018)35 cited
- → Is interleukin-6 receptor blockade (tocilizumab) beneficial or detrimental to pig-to-baboon organ xenotransplantation?(2019)35 cited
- → Serum amyloid a as an indicator of impending xenograft failure: Experimental studies(2018)16 cited
- → Correction: Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma(2018)12 cited
- → Lipid metabolic profiling and diagnostic model development for hyperlipidemic acute pancreatitis(2024)3 cited
- → Correction: Correction: Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma(2018)3 cited
- → Case report: A case of duodenal adenocarcinoma achieving significantly long survival treating with immune checkpoint inhibitors and chemotherapy without positive biomarkers(2022)2 cited
- → Efficacy and safety of fruquintinib plus trifluridine/tipiracil (TAS-102) as third-line treatment in patients with metastatic colorectal adenocarcinoma: Results from a single arm, phase 2, multicenter study.(2024)1 cited
- → Updated analysis of a phase 2 study of fruquintinib plus trifluridine/tipiracil (TAS-102) as third-line treatment in patients with metastatic colorectal adenocarcinoma.(2025)